303 related articles for article (PubMed ID: 19432535)
1. Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression.
Camargo JF; Kulkarni H; Agan BK; Gaitan AA; Beachy LA; Srinivas S; He W; Anderson S; Marconi VC; Dolan MJ; Ahuja SK
J Infect Dis; 2009 Jun; 199(12):1872-82. PubMed ID: 19432535
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
[TBL] [Abstract][Full Text] [Related]
4. HIV DNA and immune alteration during successful HAART.
Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M
Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818
[TBL] [Abstract][Full Text] [Related]
5. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
[TBL] [Abstract][Full Text] [Related]
6. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness.
Hardy GA; Imami N; Sullivan AK; Pires A; Burton CT; Nelson MR; Gazzard BG; Gotch FM
Clin Exp Immunol; 2003 Oct; 134(1):98-106. PubMed ID: 12974761
[TBL] [Abstract][Full Text] [Related]
8. Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial.
Porter BO; Anthony KB; Shen J; Hahn B; Keh CE; Maldarelli F; Blackwelder WC; Lane HC; Kovacs JA; Davey RT; Sereti I
AIDS; 2009 Jan; 23(2):203-12. PubMed ID: 19098490
[TBL] [Abstract][Full Text] [Related]
9. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
10. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
Anthony KB; Yoder C; Metcalf JA; DerSimonian R; Orenstein JM; Stevens RA; Falloon J; Polis MA; Lane HC; Sereti I
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):125-33. PubMed ID: 12794543
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.
Shive CL; Mudd JC; Funderburg NT; Sieg SF; Kyi B; Bazdar DA; Mangioni D; Gori A; Jacobson JM; Brooks AD; Hardacre J; Ammori J; Estes JD; Schacker TW; Rodriguez B; Lederman MM
J Infect Dis; 2014 Aug; 210(4):619-29. PubMed ID: 24585897
[TBL] [Abstract][Full Text] [Related]
12. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
13. Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART.
Sutherland R; Yang H; Scriba TJ; Ondondo B; Robinson N; Conlon C; Suttill A; McShane H; Fidler S; McMichael A; Dorrell L
AIDS; 2006 Apr; 20(6):821-9. PubMed ID: 16549965
[TBL] [Abstract][Full Text] [Related]
14. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
[TBL] [Abstract][Full Text] [Related]
15. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.
Resino S; Galán I; Pérez A; León JA; Seoane E; Gurbindo D; Muñoz-Fernandez MA
Clin Exp Immunol; 2004 Sep; 137(3):570-7. PubMed ID: 15320908
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness to IL-7 but not to IFN-α is diminished in CD4+ T cells from treated HIV infected patients who experience poor CD4+ T-cell recovery.
Nguyen TP; Shukla S; Asaad R; Freeman ML; Lederman MM; Harding CV; Sieg SF
AIDS; 2016 Aug; 30(13):2033-42. PubMed ID: 27191978
[TBL] [Abstract][Full Text] [Related]
17. Study of T cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART.
Shou C; Weng N; Jin Y; Feng L; Jin C; Hoextermann S; Potthoff A; Skaletz-Rorowski A; Brockmeyer NH; Wu N
Eur J Med Res; 2011 Nov; 16(11):473-9. PubMed ID: 22027639
[TBL] [Abstract][Full Text] [Related]
18. Early postseroconversion CD4 cell counts independently predict CD4 cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy.
Kulkarni H; Okulicz JF; Grandits G; Crum-Cianflone NF; Landrum ML; Hale B; Wortmann G; Tramont E; Polis M; Dolan M; Lifson AR; Agan BK; Ahuja SK; Marconi VC
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):387-95. PubMed ID: 21546844
[TBL] [Abstract][Full Text] [Related]
19. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
20. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
